Jefferies Upgrades Instil Bio to Buy, Raises Price Target to $52
Benzinga Newsdesk 1 year ago
NewsUpgradesPrice TargetAnalyst Ratings
Jefferies analyst Kelly Shi upgrades Instil Bio (NASDAQ:TIL) from Hold to Buy and raises the price target from $11 to $52.
Jefferies analyst Kelly Shi upgrades Instil Bio (NASDAQ:TIL) from Hold to Buy and raises the price target from $11 to $52.